MetLife Nonaccrual Loans - No Related Allowance decreased by 0.5% to $2.63B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 32.9%, from $1.98B to $2.63B. Over 5 years (FY 2020 to FY 2025), Nonaccrual Loans - No Related Allowance shows an upward trend with a 18.8% CAGR.
nonaccrual_loans_no_allowance| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $888.00M | $848.00M | $822.00M | $917.00M | $822.00M | $836.00M | $762.00M | $919.00M | $933.00M | $1.02B | $1.04B | $1.35B | $1.32B | $1.60B | $1.66B | $1.98B | $2.32B | $2.79B | $2.64B | $2.63B |
| QoQ Change | — | -4.5% | -3.1% | +11.6% | -10.4% | +1.7% | -8.9% | +20.6% | +1.5% | +9.1% | +1.7% | +30.5% | -2.3% | +21.4% | +3.5% | +19.2% | +17.3% | +20.4% | -5.4% | -0.5% |
| YoY Change | — | — | — | — | -7.4% | -1.4% | -7.3% | +0.2% | +13.5% | +21.8% | +35.8% | +47.0% | +41.5% | +57.4% | +60.2% | +46.3% | +75.6% | +74.2% | +59.2% | +32.9% |